Microvesicles and exosomes: New players in metabolic and cardiovascular disease

Journal of Endocrinology

Volumn 228, Issue 2, 2016, Pages R57-R71

  Lawson, Charlotte ^a   Vicencio, Jose M ^b   Yellon, Derek M ^b   Davidson, Sean M ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes; Endothelium; Exosomes; Heart; microRNA; Microvesicles; Nanoparticles

Indexed keywords

CARRIER PROTEIN; NANOPARTICLE; RNA; PROTEIN;

BLOOD CLOTTING DISORDER; BODY FLUID; CARDIOVASCULAR DISEASE; CELL STRUCTURE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; EXOSOME; HUMAN; MEMBRANE MICROPARTICLE; METABOLIC DISORDER; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN TRANSPORT; PURIFICATION; REVIEW; STEM CELL TRANSPLANTATION; ANIMAL; CELL COMMUNICATION; ENDOCRINE SYSTEM; FEMALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD COAGULATION DISORDERS; BODY FLUIDS; CARDIOVASCULAR DISEASES; CELL COMMUNICATION; DIABETES MELLITUS; ENDOCRINE SYSTEM; ENDOTHELIUM, VASCULAR; EXOSOMES; EXTRACELLULAR VESICLES; FEMALE; HUMANS; METABOLIC DISEASES; POLYCYSTIC OVARY SYNDROME; PROTEINS; RNA; SIGNAL TRANSDUCTION;

EID: 84962163443     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-15-0201     Document Type: Review

References (122)

1. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC & Andriantsitohaina R 2008 Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. American Journal of Pathology 173 1210-1219. (doi:10.2353/ajpath.2008.080228)
2. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A & Rak J 2008 Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nature Cell Biology 10 619-624. (doi:10.1038/ncb1725)
3. Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, Griffin G, Guerin C, Ho JE, Shaw SY et al. 2014 Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. European Heart Journal 35 2972-2979. (doi:10.1093/eurheartj/ehu153)
4. Ando M, Iwata A, Ozeki Y, Tsuchiya K, Akiba T & Nihei H 2002 Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney International 62 1757-1763. (doi:10.1046/j.1523-1755.2002.00627.x)
5. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor EN, Timmers L, van Rijen HV, Doevendans PA, Pasterkamp G et al. 2013 Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research 10 301-312. (doi:10.1016/j.scr.2013.01.002)
6. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E et al. 2012 Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nature Cell Biology 14 677-685. (doi:10.1038/ncb2502)
7. van Balkom BW, de Jong OG, Smits M, Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MA, Pegtel DM, Stoorvogel W & Wurdinger T 2013 Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121 3997-4006, S3991-3915. (doi:10.1182/blood-2013-02-478925)
8. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A et al. 2014 Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. Journal of Clinical Investigation 124 2136-2146. (doi:10.1172/JCI70577)
9. Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, Torre T, Siclari F, Moccetti T & Vassalli G 2014 Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovascular Research 103 530-541. (doi:10.1093/cvr/cvu167)
10. Boden G & Rao AK 2007 Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation. Current Diabetes Reports 7 223-227. (doi:10.1007/s11892-007-0035-1)
11. Boing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A & Nieuwland R 2014 Single-step isolation of extracellular vesicles by size-exclusion chromatography. Journal of Extracellular Vesicles 3 article 23430. (doi:10.3402/jev.v3.23430)
12. Breitenstein A, Tanner FC & Luscher TF 2010 Tissue factor and cardiovascular disease: quo vadis? Circulation Journal 74 3-12. (doi:10.1253/circj. CJ-09-0818)
13. Bretz NP, Ridinger J, Rupp AK, Rimbach K, Keller S, Rupp C, Marme F, Umansky L, Umansky V, Eigenbrod T et al. 2013 Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. Journal of Biological Chemistry 288 36691-36702. (doi:10.1074/jbc. M113.512806)
14. Brill A, Dashevsky O, Rivo J, Gozal Y & Varon D 2005 Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovascular Research 67 30-38. (doi:10.1016/j.cardiores.2005.04.007)
15. Brodsky SV, Zhang F, Nasjletti A & Goligorsky MS 2004 Endotheliumderived microparticles impair endothelial function in vitro. American Journal of Physiology. Heart and Circulatory Physiology 286 H1910-H1915. (doi:10.1152/ajpheart.01172.2003)
16. Brunzell JD, DavidsonM, Furberg CD, Goldberg RB, Howard BV, Stein JH & Witztum JL 2008 Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. Journal of the American College of Cardiology 51 1512-1524. (doi:10.1016/j.jacc.2008.02.034)
17. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G & Bonnerot C 2005 Exosomal-like vesicles are present in human blood plasma. International Immunology 17 879-887. (doi:10.1093/intimm/dxh267)
18. Cai ZP, Parajuli N, Zheng X & Becker L 2012 Remote ischemic preconditioning confers late protection against myocardial ischemiareperfusion injury in mice by upregulating interleukin-10. Basic Research in Cardiology 107 277. (doi:10.1007/s00395-012-0277-1)
19. Chen Y, Feng B, Li X, Ni Y & Luo Y 2012 Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes. Journal of Clinical Hypertension 14 455-460. (doi:10.1111/j.1751-7176.2012.00631.x)
20. Chen L, Wang Y, Pan Y, Zhang L, Shen C, Qin G, Ashraf M, Weintraub N, Ma G & Tang Y 2013 Cardiac progenitor-derived Exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochemical and Biophysical Research Communications 431 566-571. (doi:10.1016/j.bbrc.2013.01.015)
21. Cheng V, Kashyap SR, Schauer PR, Kirwan JP & McCrae KR 2013 Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. Surgery for Obesity and Related Diseases 9 207-212. (doi:10.1016/j.soard.2011.09.026)
22. Cheng L, Sharples RA, Scicluna BJ & Hill AF 2014 Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. Journal of Extracellular Vesicles 3 article 23743. (doi:10.3402/jev.v3.23743)
23. Colombo M, Raposo G & Thery C 2014 Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual Review of Cell and Developmental Biology 30 255-289. (doi:10.1146/annurev-cellbio-101512-122326)
24. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L & De SimoneM 2010 Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European Heart Journal 31 2765-2773. (doi:10.1093/eurheartj/ehq167)
25. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P & Halbwachs-Mecarelli L 2006 Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney International 69 1416-1423. (doi:10.1038/sj.ki.5000306)
26. Daskalopoulos G, Karkanaki A, Piouka A, Prapas N, Panidis D, Gkeleris P & Athyros VG 2015 Excess metabolic and cardiovascular risk is not manifested in all phenotypes of polycystic ovary syndrome: implications for diagnosis and treatment. Current Vascular Pharmacology 13 788-800. (doi:10.2174/1567201812666150120163025)
27. Davidson SM, Selvaraj P, He D, Boi-Doku C, Yellon RL, Vicencio JM & Yellon DM2013 Remote ischaemic preconditioning involves signalling through the SDF-1a/CXCR4 signalling axis. Basic Research in Cardiology 108 377. (doi:10.1007/s00395-013-0377-6)
28. Del Conde I, Shrimpton CN, Thiagarajan P & Lopez JA 2005 Tissuefactor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 1604-1611. (doi:10.1182/blood-2004-03-1095)
29. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B & Camussi G 2007 Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110 2440-2448. (doi:10.1182/blood-2007-03-078709)
30. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW & Radder JK 2002 Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106 2442-2447. (doi:10.1161/01.CIR.0000036596.59665.C6)
31. Dignat-George F & Boulanger CM 2011 The many faces of endothelial microparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 31 27-33. (doi:10.1161/ATVBAHA.110.218123)
32. Falati S, Liu Q, Gross P, Merrill-SkoloffG, Chou J, Vandendries E, Celi A, Croce K, Furie BC & Furie B 2003 Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 197 1585-1598. (doi:10.1084/jem.20021868)
33. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P & Dignat-George F 2006 Elevation of circulating endothelial microparticles in patients with chronic renal failure. Journal of Thrombosis and Haemostasis 4 566-573. (doi:10.1111/j.1538-7836.2005.01780.x)
34. Feng B, Chen Y, Luo Y, Chen M, Li X & Ni Y 2010 Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 208 264-269. (doi:10.1016/j.atherosclerosis.2009.06.037)
35. Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, Granjon A, Errazuriz E, Lefai E, Vidal H & Rome S 2014 Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle 13 78-89. (doi:10.4161/cc.26808)
36. Gaceb A, Martinez MC & Andriantsitohaina R 2014 Extracellular vesicles: new players in cardiovascular diseases. The International Journal of Biochemistry & Cell Biology 50 24-28. (doi:10.1016/j.biocel.2014.01.018)
37. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C & Camussi G 2011 Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrology, Dialysis, Transplantation 26 1474-1483. (doi:10.1093/ndt/gfr015)
38. Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas E & Ferdinandy P 2014 Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. Journal of Molecular and Cellular Cardiology 68 75-78. (doi:10.1016/j.yjmcc.2014.01.004)
39. Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, Searles CD & Davis ME 2015 Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circulation Research 116 255-263. (doi:10.1161/CIRCRESAHA.116.304360)
40. Gunduz Z, Dursun I, Tulpar S, Bastug F, Baykan A, Yikilmaz A, Patiroglu T, Poyrazoglu HM, Akin L, Yel S et al. 2012 Increased endothelial microparticles in obese and overweight children. Journal of Pediatric Endocrinology & Metabolism 25 1111-1117. (doi:10.1515/jpem-2012-0194)
41. Hansson GK, Libby P & Tabas I 2015 Inflammation and plaque vulnerability. Journal of Internal Medicine 278 483-493. (doi:10.1111/joim.12406)
42. Hargett LA & Bauer NN 2013 On the origin of microparticles: From "platelet dust" to mediators of intercellular communication. Pulmonary Circulation 3 329-340. (doi:10.4103/2045-8932.114760)
43. Hausenloy DJ & Yellon DM 2008 Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovascular Research 79 377-386. (doi:10.1093/cvr/cvn114)
44. Hausenloy DJ & Yellon DM 2013 Myocardial ischemia-reperfusion injury: a neglected therapeutic target. Journal of Clinical Investigation 123 92-100. (doi:10.1172/JCI62874)
45. Hausenloy DJ, Tsang A & Yellon DM 2005 The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends in Cardiovascular Medicine 15 69-75. (doi:10.1016/j.tcm.2005.03.001)
46. Headland SE, Jones HR, D'Sa AS, Perretti M & Norling LV 2014 Cuttingedge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Scientific Reports 4 5237. (doi:10.1038/srep05237)
47. Heinrich LF, Andersen DK, Cleasby ME & Lawson C 2015 Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells. British Journal of Nutrition 113 1704-1711. (doi:10.1017/S0007114515001117)
48. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M et al. 2012 Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biology 14 249-256. (doi:10.1038/ncb2441)
49. Hou S, Grillo D, Williams CL, Wasserstrom JA, Szleifer I & Zhao M 2014 Membrane phospholipid redistribution in cancer micro-particles and implications in the recruitment of cationic protein factors. Journal of Extracellular Vesicles 3 article 22653. (doi:10.3402/jev.v3.22653)
50. Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK et al. 2013 Endothelial Microparticle-Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles. Circulation 128 2026-2038. (doi:10.1161/CIRCULATIONAHA.113.001720)
51. Jayachandran M, Litwiller RD, Lahr BD, Bailey KR, Owen WG, Mulvagh SL, Heit JA, Hodis HN, Harman SM & Miller VM 2011 Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. Journal of Cardiovascular Translational Research 4 811-822. (doi:10.1007/s12265-011-9296-9)
52. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE & Sturk A 2001 Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thrombosis and Haemostasis 85 810-820
53. de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, Schiffelers RM, Gucek M & van Balkom BW 2012 Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. Journal of Extracellular Vesicles 1 article 18396. (doi:10.3402/jev.v1i0.18396)
54. Jorgensen MM, Baek R & Varming K 2015a Potentials and capabilities of the extracellular vesicle (EV) array. Journal of Extracellular Vesicles 4 26048. (doi:10.3402/jev.v4.26048)
55. Kim HK, Song KS, Chung JH, Lee KR & Lee SN 2004 Platelet microparticles induce angiogenesis in vitro. British Journal of Haematology 124 376-384. (doi:10.1046/j.1365-2141.2003.04773.x)
56. Kim SJ, Moon GJ, Cho YH, Kang HY, Hyung NK, Kim D, Lee JH, Nam JY & Bang OY 2012 Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS ONE 7 e37036. (doi:10.1371/journal.pone.0037036)
57. Koiou E, Tziomalos K, Katsikis I, Kalaitzakis E, Kandaraki EA, Tsourdi EA, Delkos D, Papadakis E & Panidis D 2011 Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. European Journal of Endocrinology 165 63-68. (doi:10.1530/EJE-11-0144)
58. Koiou E, Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA & Panidis D 2013 Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome. Gynecological Endocrinology 29 250-253. (doi:10.3109/09513590.2012.743005)
59. Kruger S, Abd Elmageed ZY, Hawke DH, Worner PM, Jansen DA, Abdel-Mageed AB, Alt EU & Izadpanah R 2014 Molecular characterization of exosome-like vesicles from breast cancer cells. BMC Cancer 14 44. (doi:10.1186/1471-2407-14-44)
60. Lacroix R & Dignat-George F 2012 Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thrombosis Research 129(Suppl 2) S27-S29. (doi:10.1016/j.thromres.2012.02.025)
61. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J & Dignat-George F 2012 Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. Journal of Thrombosis and Haemostasis 10 437-446. (doi:10.1111/j.1538-7836.2011.04610.x)
62. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM et al. 2010 Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research 4 214-222. (doi:10.1016/j.scr.2009.12.003)
63. Lakhter AJ & Sims EK 2015 Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders. Molecular Endocrinology 29 1535-1548. (doi:10.1210/me.2015-1206)
64. Larson MC, WoodliffJE, Hillery CA, Kearl TJ & Zhao M 2012 Phosphatidylethanolamine is externalized at the surface of microparticles. Biochimica et Biophysica Acta 1821 1501-1507. (doi:10.1016/j.bbalip.2012.08.017)
65. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, Sdrimas K, Fernandez-Gonzalez A & Kourembanas S 2012 Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126 2601-2611. (doi:10.1161/CIRCULATIONAHA.112.114173)
66. Leroyer AS, Ebrahimian TG, Cochain C, Recalde A, Blanc-Brude O, Mees B, Vilar J, Tedgui A, Levy BI, Chimini G et al. 2009 Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 119 2808-2817. (doi:10.1161/CIRCULATIONAHA.108.816710)
67. Lindhardsen J, Kristensen SL & AhlehoffO 2015 Management of cardiovascular risk in patients with chronic inflammatory diseases: current evidence and future perspectives. American Journal of Cardiovascular Drugs [in press]. (doi:10.1007/s40256-015-0141-4)
68. Lobb RJ, Becker M, Wen SW, Wong CS, Wiegmans AP, Leimgruber A & Moller A 2015 Optimized exosome isolation protocol for cell culture supernatant and human plasma. Journal of Extracellular Vesicles 4 27031. (doi:10.3402/jev.v4.27031)
69. Macey MG, Enniks N & Bevan S 2011 Flow cytometric analysis of microparticle phenotype and their role in thrombin generation. Cytometry. Part B, Clinical Cytometry 80 57-63. (doi:10.1002/cyto.b.20551)
70. Mackie AR, Klyachko E, Thorne T, Schultz KM, MillayM, Ito A, Kamide CE, Liu T, Gupta R, Sahoo S et al. 2012 Sonic hedgehog-modified human CD34C cells preserve cardiac function after acute myocardial infarction. Circulation Research 111 312-321. (doi:10.1161/CIRCRESAHA.112.266015)
71. Martin S, Tesse A, Hugel B, Martinez MC, Morel O, Freyssinet JM & Andriantsitohaina R 2004 Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 109 1653-1659. (doi:10.1161/01.CIR.0000124065.31211.6E)
72. Mathur S, Walley KR, Wang Y, Indrambarya T & Boyd JH 2011 Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circulation Journal 75 2445-2452. (doi:10.1253/circj. CJ-11-0194)
73. Menasche P 2015 Stem cells in the management of advanced heart failure. Current Opinion in Cardiology 30 179-185. (doi:10.1097/HCO.0000000000000138)
74. Mesri M & Altieri DC 1998 Endothelial cell activation by leukocyte microparticles. Journal of Immunology 161 4382-4387
75. Meziani F, Delabranche X, Asfar P & Toti F 2010 Bench-to-bedside review: circulating microparticles-a new player in sepsis? Critical Care 14 236. (doi:10.1186/cc9231)
76. Moldovan L, Batte K, Wang Y, Wisler J & Piper M 2013 Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. Methods in Molecular Biology 1024 129-145. (doi:10.1007/978-1-62703-453-1_10)
77. Nomura S, Komiyama Y, Murakami T, Funatsu A, Kokawa T, Sugo T, Matsuda M & Yasunaga K 1993 Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals. International Journal of Hematology 58 203-212
78. Ogata N, Nomura S, Shouzu A, Imaizumi M, ArichiM & MatsumuraM2006 Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Research and Clinical Practice 73 241-248. (doi:10.1016/j.diabres.2006.01.014)
79. Omoto S, Nomura S, Shouzu A, Hayakawa T, Shimizu H, Miyake Y, Yonemoto T, Nishikawa M, Fukuhara S & Inada M 1999 Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy. Nephron 81 271-277. (doi:10.1159/000045292)
80. Ong SG, Lee WH, Huang M, Dey D, Kodo K, Sanchez-Freire V, Gold JD & Wu JC 2014 Cross Talk of Combined Gene and Cell Therapy in Ischemic Heart Disease: Role of Exosomal MicroRNA Transfer. Circulation 130 S60-S69. (doi:10.1161/CIRCULATIONAHA.113.007917)
81. Perrone-Filardi P, Paolillo S, Costanzo P, Savarese G, Trimarco B & Bonow RO 2015 The role of metabolic syndrome in heart failure. European Heart Journal 36 2630-2634. (doi:10.1093/eurheartj/ehv350)
82. Peters SA, Huxley RR & Woodward M 2014 Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 57 1542-1551. (doi:10.1007/s00125-014-3260-6)
83. Pironti G, Strachan RT, Abraham D, Mon-Wei YuS, Chen M, Chen W, Hanada K, Mao L, Watson LJ & Rockman HA 2015 Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors. Circulation 131 2120-2130. (doi:10.1161/CIRCULATIONAHA.115.015687)
84. van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG & Nieuwland R 2010 Optical and non-optical methods for detection and characterization of microparticles and exosomes. Journal of Thrombosis and Haemostasis 8 2596-2607. (doi:10.1111/j.1538-7836.2010.04074.x)
85. van der Pol E, Boing AN, Harrison P, Sturk A & Nieuwland R 2012 Classification, functions, and clinical relevance of extracellular vesicles. Pharmacological Reviews 64 676-705. (doi:10.1124/pr.112.005983)
86. Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, Ilkovics L, Hampl A, Crha I, Jandakova E et al. 2015 Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. Journal of Extracellular Vesicles 4 article 25530. (doi:10.3402/jev.v4.25530)
87. Raposo G & Stoorvogel W 2013 Extracellular vesicles: exosomes, microvesicles, and friends. Journal of Cell Biology 200 373-383. (doi:10.1083/jcb.201211138)
88. Rask-Madsen C & King GL 2013 Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metabolism 17 20-33. (doi:10.1016/j.cmet.2012.11.012)
89. Raturi A, Miersch S, Hudson JW & Mutus B 2008 Platelet microparticleassociated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochimica et Biophysica Acta 1778 2790-2796. (doi:10.1016/j.bbamem.2008.07.003)
90. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H et al. 2011 Exosomes from human CD34(C) stem cells mediate their proangiogenic paracrine activity. Circulation Research 109 724-728. (doi:10.1161/CIRCRESAHA.111.253286)
91. Scholz T, Temmler U, Krause S, Heptinstall S & Losche W 2002 Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thrombosis and Haemostasis 88 1033-1038
92. Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, Leek R, Edelmann M, Kessler B, Sainson RC et al. 2010 New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 116 2385-2394. (doi:10.1182/blood-2009-08-239228)
93. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV & Ataullakhanov FI 2007 Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets. Thrombosis and Haemostasis 97 425-434. (doi:10.1160/TH06-06-0313)
94. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM & Breakefield XO 2008 Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology 10 1470-1476. (doi:10.1038/ncb1800)
95. Sommeijer DW, Joop K, Leyte A, Reitsma PH & ten Cate H 2005 Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. Journal of Thrombosis and Haemostasis 3 1168-1171. (doi:10.1111/j.1538-7836.2005.01403.x)
96. Sreekumar PG, Kannan R, Kitamura M, Spee C, Barron E, Ryan SJ & Hinton DR 2010 aB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS ONE 5 e12578. (doi:10.1371/journal.pone.0012578)
97. Stepanian A, Bourguignat L, Hennou S, Coupaye M, Hajage D, Salomon L, Alessi MC, Msika S & de Prost D 2013 Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity 21 2236-2243. (doi:10.1002/oby.20365)
98. Suades R, Padro T & Badimon L 2015 The Role of Blood-Borne Microparticles in Inflammation and Hemostasis. Seminars in Thrombosis and Hemostasis 41 590-606. (doi:10.1055/s-0035-1556591)
99. Teede H, Deeks A & Moran L 2010 Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine 8 41. (doi:10.1186/1741-7015-8-41)
100. Thery C, Amigorena S, Raposo G & Clayton A 2006 Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology Chapter 3, Unit 3.22. (doi:10.1002/0471143030.cb0322s30)
101. Thery C, Ostrowski M & Segura E 2009 Membrane vesicles as conveyors of immune responses. Nature Reviews. Immunology 9 581-593. (doi:10.1038/nri2567)
102. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B & Simons M 2008 Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319 1244-1247. (doi:10.1126/science.1153124)
103. Tsimerman G, Roguin A, Bachar A, Melamed E, Brenner B & Aharon A 2011 Involvement of microparticles in diabetic vascular complications. Thrombosis and Haemostasis 106 310-321. (doi:10.1160/TH10-11-0712)
104. Tushuizen ME, Diamant M, Peypers EG, Hoek FJ, Heine RJ, Sturk A & Nieuwland R 2012 Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation. Thrombosis Research 130 115-121. (doi:10.1016/j.thromres.2011.09.003)
105. Ueba T, Haze T, Sugiyama M, Higuchi M, Asayama H, Karitani Y, Nishikawa T, Yamashita K, Nagami S, Nakayama T et al. 2008 Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thrombosis and Haemostasis 100 280-285. (doi:10.1160/TH07-11-0668)
106. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ & Lotvall JO 2007 Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 9 654-659. (doi:10.1038/ncb1596)
107. Vicencio JM, Yellon DM, Sivaraman V, Das D, Boi-Doku C, Arjun S, Zheng Y, Riquelme JA, Kearney J, Sharma V et al. 2015 Plasma exosomes protect the myocardium from ischemia-reperfusion injury. Journal of the American College of Cardiology 65 1525-1536. (doi:10.1016/j.jacc.2015.02.026)
108. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M & Sanchez-Madrid F 2013 Sumoylated hnRNPA2B1 controls the sorting ofmiRNAs into exosomes through binding to specific motifs. Nature Communications 4 2980. (doi:10.1038/ncomms3980)
109. Vrijsen KR, Sluijter JP, Schuchardt MW, van Balkom BW, Noort WA, Chamuleau SA & Doevendans PA 2010 Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. Journal of Cellular and Molecular Medicine 14 1064-1070. (doi:10.1111/j.1582-4934.2010.01081.x)
110. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP & Mackman N 2011 Monocytic microparticles activate endothelial cells in an IL-1b-dependent manner. Blood 118 2366-2374. (doi:10.1182/blood-2011-01-330878)
111. Wang Y, Chen LM & Liu ML 2014a Microvesicles and diabetic complications-novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacologica Sinica 35 433-443. (doi:10.1038/aps.2013.188)
112. Wang X, Huang W, Liu G, Cai W, Millard RW, Wang Y, Chang J, Peng T & Fan GC 2014b Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. Journal of Molecular and Cellular Cardiology 74 139-150. (doi:10.1016/j.yjmcc.2014.05.001)
113. Welton JL, Webber JP, Botos LA, Jones M & Clayton A 2015 Ready-made chromatography columns for extracellular vesicle isolation from plasma. Journal of Extracellular Vesicles 4 27269. (doi:10.3402/jev.v4.27269)
114. Werner N, Wassmann S, Ahlers P, Kosiol S & Nickenig G 2006 Circulating CD31C/annexin VC apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 26 112-116. (doi:10.1161/01.ATV.0000191634.13057.15)
115. Willis GR, Connolly K, Ladell K, Davies TS, Guschina IA, Ramji D, Miners K, Price DA, Clayton A, James PE et al. 2014 Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles. Human Reproduction 29 2756-2763. (doi:10.1093/humrep/deu281)
116. Witwer KW, Buzas EI, Bemis LT, Bora A, Lasser C, Lotvall J, Nolte 't-Hoen EN, PiperMG, Sivaraman S, Skog J et al. 2013 Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. Journal of Extracellular Vesicles 2 article 20360. (doi:10.3402/jev.v2i0.20360)
117. Wolf P 1967 The nature and significance of platelet products in human plasma. British Journal of Haematology 13 269-288. (doi:10.1111/j.1365-2141.1967.tb08741.x)
118. Yellon DM & Davidson SM 2014 Exosomes: nanoparticles involved in cardioprotection? Circulation Research 114 325-332. (doi:10.1161/CIRCRESAHA.113.300636)
119. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH et al. 2005 Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. Journal of Clinical Investigation 115 326-338. (doi:10.1172/JCI200522326)
120. Yu B, Kim HW, Gong M, Wang J, Millard RW, Wang Y, Ashraf M & Xu M 2015 Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. International Journal of Cardiology 182C 349-360. (doi:10.1016/j.ijcard.2014.12.043)
121. Zhang Y, Zhang X, Shan P, Hunt CR, Pandita TK & Lee PJ 2013 A protective Hsp70-TLR4 pathway in lethal oxidant lung injury. Journal of Immunology 191 1393-1403. (doi:10.4049/jimmunol.1300052)
122. Zhang B, Yin Y, Lai RC, Tan SS, Choo AB & Lim SK 2014 Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells and Development 23 1233-1244. (doi:10.1089/scd.2013.0479)